Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,789 | -17,560 | -6,539 | -4,070 | -19,404 |
| Depreciation Amortization | 11 | 4 | 2 | 1 | 6 |
| Other Working Capital | -2,513 | -2,507 | -1,536 | -1,371 | -112 |
| Other Operating Activity | 11,317 | 8,682 | 568 | 255 | 1,713 |
| Operating Cash Flow | $-14,974 | $-11,381 | $-7,506 | $-5,185 | $-17,796 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -150 | -21 | -3 | -3 | -7 |
| Net Acquisitions | 509 | 509 | N/A | N/A | N/A |
| Other Investing Activity | -82 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $277 | $489 | $-3 | $-3 | $-7 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 16,726 | 1,763 | 1,763 | 1,763 | 24,375 |
| Financing Cash Flow | $16,726 | $1,763 | $1,763 | $1,763 | $24,375 |
| Beginning Cash Position | 27,061 | 27,061 | 27,061 | 27,061 | 20,489 |
| End Cash Position | 29,091 | 17,933 | 21,316 | 23,637 | 27,061 |
| Net Cash Flow | $2,030 | $-9,129 | $-5,745 | $-3,425 | $6,572 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,974 | -11,381 | -7,506 | -5,185 | -17,796 |
| Capital Expenditure | -150 | -21 | -3 | -3 | -7 |
| Free Cash Flow | -15,124 | -11,401 | -7,508 | -5,188 | -17,803 |